Ainos、治療法が限られている希少疾患であるシェーグレン症候群の治療薬VELDONAの台湾での臨床試験開始計画を発表 Ainos, Inc Sep 19, 2024 21:00 JST Read More
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024 NEC Corporation Apr 10, 2024 12:36 HKT/SGT Read More
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 NEC Corporation Mar 05, 2024 08:05 HKT/SGT Read More
アバンセ・クリニカル、招待を受け、韓国バイオ企業45社に韓国・オーストラリアから米国へのGlobalReady医薬品開発経路を説明 Avance Clinical Oct 19, 2023 12:00 JST Read More
アバンセ・クリニカルがASCO & BIO 2023に参加 初期段階のオンコロジー試験はより精緻化、より多くの患者を必要とする Avance Clinical May 30, 2023 20:00 JST Read More
New Data Showing that Transgene and NEC's Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023 NEC Corporation Apr 18, 2023 16:13 HKT/SGT Read More
アバンセ・クリニカルのCEOが2023年エボリューション・ヨーロッパ・サミットのグローバル・バイオファーマ・パネルに参加 Avance Clinical Apr 18, 2023 11:00 JST Read More
Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding Verseon International Corporation Dec 14, 2022 22:45 JST Read More
アバンセ・クリニカルがInternational Health AwardのBiotech CRO Services部門で受賞 Avance Clinical Sep 29, 2022 12:00 JST Read More
Glenn Haifer博士とAmpersand Capital Partners、オーストラリアの生物製剤CDMO Luina Bioを買収、AcuraBioにブランド変更 AcuraBio Aug 31, 2022 13:00 JST Read More
SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development DIA Jun 15, 2022 09:30 JST Read More
Elevating Australia's Scientific Acumen: Large Molecule Facility Doubles Size of Australia's Top Bioanalytical Laboratory Agilex Biolabs May 12, 2022 16:00 JST Read More
Joint Research Shows that DENSO's Microalga, Coccomyxa sp. KJ Has Virucidal Effect against COVID-19 Denso Mar 24, 2022 10:05 HKT/SGT Read More
